Fidelity International’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Buy |
72,079
+34,045
| +90% | +$8.95M | 0.01% | 492 |
|
|
2026
Q1 | $10.1M | Buy |
38,034
+35,195
| +1,240% | +$9.53M | 0.01% | 584 |
|
|
2025
Q4 | $712K | Sell |
2,839
-2,102
| -43% | -$558K | ﹤0.01% | 863 |
|
|
2025
Q3 | $1.42M | Sell |
4,941
-308,826
| -98% | -$82.7M | ﹤0.01% | 761 |
|
|
2025
Q2 | $82.4M | Sell |
313,767
-68,308
| -18% | -$16.6M | 0.07% | 253 |
|
|
2025
Q1 | $88.9M | Sell |
382,075
-369
| -0.1% | -$89.5K | 0.08% | 237 |
|
|
2024
Q4 | $87.7M | Sell |
382,444
-9,923
| -3% | -$2.28M | 0.08% | 235 |
|
|
2024
Q3 | $87.7M | Sell |
392,367
-5,527
| -1% | -$1.21M | 0.08% | 248 |
|
|
2024
Q2 | $81M | Buy |
397,894
+7,603
| +2% | +$1.55M | 0.08% | 244 |
|
|
2024
Q1 | $85.3M | Sell |
390,291
-2,649
| -0.7% | -$584K | 0.08% | 245 |
|
|
2023
Q4 | $89.3M | Sell |
392,940
-13,209
| -3% | -$2.77M | 0.09% | 234 |
|
|
2023
Q3 | $81.7M | Sell |
406,149
-65,765
| -14% | -$13.9M | 0.1% | 228 |
|
|
2023
Q2 | $97.8M | Sell |
471,914
-58,127
| -11% | -$11.3M | 0.11% | 210 |
|
|
2023
Q1 | $104M | Buy |
530,041
+31,329
| +6% | +$6.45M | 0.12% | 187 |
|
|
2022
Q4 | $101M | Buy |
498,712
+213,504
| +75% | +$41.7M | 0.12% | 193 |
|
|
2022
Q3 | $50.2M | Buy |
+285,208
| New | +$58.4M | 0.06% | 285 |
|
|
2021
Q2 | – | Sell |
-5
| Closed | -$1K | – | 981 |
|
|
2021
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 919 |
|
|
2020
Q4 | $1K | Hold |
5
| – | – | ﹤0.01% | 887 |
|
|
2020
Q3 | $1K | Buy |
+5
| New | +$792 | ﹤0.01% | 877 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | -$1K | – | 909 |
|
|
2019
Q4 | $1K | Sell |
3
-21,114
| -100% | -$3.05M | ﹤0.01% | 896 |
|
|
2019
Q3 | $3.05M | Sell |
21,117
-12,222
| -37% | -$1.78M | ﹤0.01% | 588 |
|
|
2019
Q2 | $4.95M | Sell |
33,339
-1,004
| -3% | -$140K | 0.01% | 531 |
|
|
2019
Q1 | $4.51M | Sell |
34,343
-12,489
| -27% | -$1.54M | 0.01% | 520 |
|
|
2018
Q4 | $5.08M | Sell |
46,832
-34,056
| -42% | -$4.56M | 0.01% | 512 |
|
|
2018
Q3 | $12.1M | Sell |
80,888
-17,908
| -18% | -$2.72M | 0.02% | 462 |
|
|
2018
Q2 | $15.2M | Buy |
98,796
+26,789
| +37% | +$4.04M | 0.02% | 438 |
|
|
2018
Q1 | $10M | Buy |
72,007
+16,836
| +31% | +$2.47M | 0.03% | 355 |
|
|
2017
Q4 | $7.56M | Buy |
55,171
+5,658
| +11% | +$748K | 0.02% | 378 |
|
|
2017
Q3 | $6.42M | Buy |
+49,513
| New | +$6.6M | 0.02% | 379 |
|
Other funds holding LH
Fidelity International's LH Position: Q2 2026 in Review
Fidelity International increased its Labcorp (LH) stake by 90% in Q2 2026, buying an estimated $8.95M and bringing the position to 72,079 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #492.
Fidelity International first reported a position in LH in Q3 2017 and has held it in 29 quarters since. The position peaked at $104M in Q1 2023. 1,057 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Fidelity International held 72,079 shares of Labcorp worth $20.2M as of Q2 2026.
- Fidelity International bought 34,045 Labcorp shares in Q2 2026, an estimated $8.95M.
- Labcorp made up 0.01% of Fidelity International's portfolio in Q2 2026, its #492 holding.
- Fidelity International first reported a position in Labcorp in Q3 2017 and has held it in 29 quarters since.
- Fidelity International's Labcorp position peaked at $104M in Q1 2023.
- 1,057 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.